Sofinnova Partners Closes €650M Fund to Boost Next-Generation Biotech and Medtech Startups
Sofinnova Partners, one of Europe’s leading life sciences venture capital firms, has closed its latest flagship fund, Sofinnova Capital XI, at €650 million ($750 million)—substantially…
Read More...
Read More...
